Artículo original
Evaluación de la sobreexpresión de proteína HER2 en cáncer vesical no músculo invasivo con énfasis en el grado tumoral y en la recurrencia
Evaluation of HER2 protein overexpression in non-muscle invasive bladder cancer with emphasis on tumour grade and recurrence
Leído
3184
Vecesse ha leído el artículo
616
Total PDF
2568
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 0 | 5 | 5 |
| 2025 10 | 0 | 5 | 5 |
| 2025 9 | 0 | 3 | 3 |
| 2025 8 | 0 | 2 | 2 |
| 2025 7 | 0 | 2 | 2 |
| 2025 6 | 0 | 1 | 1 |
| 2025 5 | 0 | 1 | 1 |
| 2025 4 | 0 | 1 | 1 |
| 2025 3 | 0 | 2 | 2 |
| 2025 2 | 0 | 1 | 1 |
| 2025 1 | 0 | 1 | 1 |
| 2024 12 | 0 | 1 | 1 |
| 2024 10 | 0 | 1 | 1 |
| 2024 9 | 0 | 2 | 2 |
| 2024 8 | 0 | 1 | 1 |
| 2024 7 | 0 | 1 | 1 |
| 2024 5 | 0 | 4 | 4 |
| 2024 4 | 0 | 1 | 1 |
| 2024 3 | 0 | 2 | 2 |
| 2024 1 | 0 | 1 | 1 |
| 2023 12 | 0 | 1 | 1 |
| 2023 11 | 0 | 3 | 3 |
| 2023 10 | 0 | 2 | 2 |
| 2023 8 | 0 | 2 | 2 |
| 2023 7 | 0 | 1 | 1 |
| 2023 6 | 0 | 1 | 1 |
| 2023 5 | 0 | 3 | 3 |
| 2023 4 | 0 | 2 | 2 |
| 2023 3 | 1 | 0 | 1 |
| 2023 2 | 0 | 2 | 2 |
| 2022 1 | 0 | 1 | 1 |
| 2022 11 | 0 | 3 | 3 |
| 2022 9 | 0 | 2 | 2 |
| 2022 8 | 0 | 1 | 1 |
| 2022 7 | 0 | 1 | 1 |
| 2022 6 | 0 | 1 | 1 |
| 2022 5 | 0 | 4 | 4 |
| 2022 4 | 0 | 1 | 1 |
| 2022 3 | 0 | 1 | 1 |
| 2022 2 | 0 | 3 | 3 |
| 2021 12 | 0 | 3 | 3 |
| 2021 11 | 0 | 4 | 4 |
| 2021 9 | 0 | 2 | 2 |
| 2021 8 | 0 | 1 | 1 |
| 2021 6 | 0 | 7 | 7 |
| 2021 5 | 0 | 1 | 1 |
| 2021 4 | 0 | 4 | 4 |
| 2021 3 | 0 | 2 | 2 |
| 2021 2 | 0 | 1 | 1 |
| 2020 1 | 0 | 1 | 1 |
| 2020 12 | 0 | 1 | 1 |
| 2020 9 | 0 | 1 | 1 |
| 2020 8 | 0 | 4 | 4 |
| 2020 7 | 0 | 1 | 1 |
| 2020 3 | 0 | 2 | 2 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 0 | 1 | 1 |
| 2019 11 | 0 | 3 | 3 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 0 | 1 | 1 |
| 2019 7 | 0 | 2 | 2 |
| 2019 6 | 0 | 15 | 15 |
| 2019 3 | 1 | 2 | 3 |
| 2018 2 | 3 | 2 | 5 |
| 2018 1 | 6 | 2 | 8 |
| 2017 12 | 6 | 0 | 6 |
| 2017 11 | 10 | 0 | 10 |
| 2017 10 | 7 | 5 | 12 |
| 2017 9 | 14 | 1 | 15 |
| 2017 8 | 12 | 1 | 13 |
| 2017 7 | 6 | 5 | 11 |
| 2017 6 | 7 | 8 | 15 |
| 2017 5 | 8 | 3 | 11 |
| 2017 4 | 10 | 5 | 15 |
| 2017 3 | 7 | 21 | 28 |
| 2017 2 | 19 | 4 | 23 |
| 2016 1 | 15 | 1 | 16 |
| 2016 12 | 27 | 7 | 34 |
| 2016 11 | 24 | 8 | 32 |
| 2016 10 | 28 | 3 | 31 |
| 2016 9 | 35 | 3 | 38 |
| 2016 8 | 33 | 6 | 39 |
| 2016 7 | 24 | 2 | 26 |
| 2016 6 | 17 | 16 | 33 |
| 2016 5 | 23 | 15 | 38 |
| 2016 4 | 18 | 28 | 46 |
| 2016 3 | 27 | 21 | 48 |
| 2016 2 | 13 | 19 | 32 |
| 2015 1 | 16 | 31 | 47 |
| 2015 12 | 20 | 21 | 41 |
| 2015 11 | 20 | 17 | 37 |
| 2015 10 | 18 | 16 | 34 |
| 2015 9 | 15 | 10 | 25 |
| 2015 8 | 33 | 9 | 42 |
| 2015 7 | 28 | 10 | 38 |
| 2015 6 | 3 | 4 | 7 |
| 2015 5 | 12 | 5 | 17 |
| 2015 4 | 13 | 18 | 31 |
| 2015 3 | 20 | 11 | 31 |
| 2015 2 | 10 | 7 | 17 |
| 2015 1 | 25 | 3 | 28 |
| 2014 12 | 44 | 21 | 65 |
| 2014 11 | 29 | 4 | 33 |
| 2014 10 | 49 | 17 | 66 |
| 2014 9 | 43 | 5 | 48 |
| 2014 8 | 25 | 4 | 29 |
| 2014 7 | 29 | 6 | 35 |
| 2014 6 | 31 | 6 | 37 |
| 2014 5 | 30 | 8 | 38 |
| 2014 4 | 16 | 10 | 26 |
| 2014 3 | 23 | 10 | 33 |
| 2014 2 | 19 | 6 | 25 |
| 2014 1 | 10 | 5 | 15 |
| 2013 12 | 11 | 3 | 14 |
| 2013 11 | 20 | 8 | 28 |
| 2013 10 | 12 | 4 | 16 |
| 2013 9 | 20 | 7 | 27 |
| 2013 8 | 14 | 4 | 18 |
| 2013 7 | 7 | 4 | 11 |
| 2011 3 | 1502 | 0 | 1502 |
Mostrar todo
